The latest study from the Jill Roberts Institute, "The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation," was published on September 6 in Nature. To read more, click here.     Dr. Gregory Sonnenberg wins inaugural award from the Society for Mucosal Immunology. To read more, click here.  The Kenneth Rainin Foundation awarded Dr. Iliyan Iliev and colleagues from Mount Sinai a $250,000 Synergy Award to examine the composition of the fungal community in babies born to mothers with inflammatory bowel disease. To read more, click here. Dr. Randy Longman received the Irma T. Hirschl Career Scientist Award and the New York Crohn’s Foundation Award.    

The Jill Roberts Institute for Research in Inflammatory Bowel Disease

The Jill Roberts Institute for Research in Inflammatory Bowel Disease

A Message From the Director

We welcome you to the Jill Roberts Institute for Research in Inflammatory Bowel Disease (IBD). The mission of the Institute is to establish a multidisciplinary center of excellence that will accelerate new cutting edge scientific discoveries at both the basic and translational level, which collectively will advance innovative preventative and therapeutic approaches for IBD and other related inflammatory diseases. Our goal is to propel a paradigm shift in how we approach the research, treatment, prevention and cure of chronic inflammatory diseases by establishing interactive and successful collaborations between basic researchers, clinicians, pathologists, surgeons and bioinformaticians.

 

Please explore the website: meet our faculty, staff and trainees, learn more about our research programs and teaching efforts, and read about our recent publications and press releases. 

 

Please contact us if you have any questions.

 

Sincerely,

 

David Artis

Michael Kors Professor of Immunology

Director, Jill Roberts Institute

Weill Cornell Medicine

 

Continue Reading About Us